Leber Congenital Amaurosis (LCA) is a rare genetic eye disorder that affects vision from birth or early childhood. It is caused by mutations in genes that are essential for the function of the retina, the light-sensitive tissue at the back of the eye. Children with LCA often experience severe vision loss or blindness, making it difficult for them to see light or shapes. Despite the challenges, research into LCA is ongoing, and advancements in gene therapy offer hope for treatment. Organizations like the Foundation Fighting Blindness are dedicated to funding research and supporting families affected by this condition, aiming to improve the quality of life for those with LCA.